OTTO: A new strategy to extract mental disease-relevant combinations of GWAS hits from individuals

Molecular Psychiatry

Volumn 23, Issue 2, 2018, Pages 476-486

  Ehrenreich, H ^a,b   Mitjans, M ^a   Van Der Auwera, S ^c   Centeno, T P ^d   Begemann, M ^a   Grabe, H J ^c   Bonn, S ^b,d   Nave, K A ^a,b  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b Deutsche Forschungsgemeinschaft   (Germany)

^c UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GUANINE; THYMINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTISM; CONTROLLED STUDY; FEMALE; GENETIC HETEROGENEITY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROCEDURES; PSYCHOSIS; RISK FACTOR;

ADULT; AGED; FEMALE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA;

EID: 85001602413     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2016.208     Document Type: Article

References (31)

1. Mah S, Nelson MR, Delisi LE, Reneland RH, Markward N, James MR et al. Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia. Mol Psychiatry 2006; 11: 471-478.
2. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421-427.
3. Stepniak B, Papiol S, Hammer C, Ramin A, Everts S, Hennig L et al. Accumulated environmental risk determining age at schizophrenia onset: a deep phenotypingbased study. Lancet Psychiatry 2014; 1: 444-453.
4. Papiol S, Mitjans M, Assogna F, Piras F, Hammer C, Caltagirone C et al. Polygenic determinants of white matter volume derived from GWAS lack reproducibility in a replicate sample. Transl Psychiatry 2014; 4: e362.
5. Terwisscha van Scheltinga AF, Bakker SC, van Haren NE, Derks EM, Buizer-Voskamp JE, Boos HB et al. Genetic schizophrenia risk variants jointly modulate total brain and white matter volume. Biol Psychiatry 2013; 73: 525-531.
6. Van der Auwera S, Wittfeld K, Homuth G, Teumer A, Hegenscheid K, Grabe HJ. No association between polygenic risk for schizophrenia and brain volume in the general population. Biol Psychiatry 2015; 78: E41-E42.
7. Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N et al. Schizophrenia risk from complex variation of complement component 4. Nature 2016; 530: 177-183.
8. Hammer C, Begemann M, McLaren PJ, Bartha I, Michel A, Klose B et al. Amino acid variation in HLA class II proteins is a major determinant of humoral response to common viruses. Am J Hum Genet 2015; 97: 738-743.
9. Hammer C, Wanitchakool P, Sirianant L, Papiol S, Monnheimer M, Faria D et al. A coding variant of ANO10, affecting volume regulation of macrophages, is associated with borrelia seropositivity. Mol Med 2015; 21: 26-37.
10. Claussnitzer M, Dankel SN, Kim KH, Quon G, Meuleman W, Haugen C et al. FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 2015; 373: 895-907.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision. American Psychiatric Press: Washington, DC, USA, 2000.
12. Begemann M, Grube S, Papiol S, Malzahn D, Krampe H, Ribbe K et al. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Arch Gen Psychiatry 2010; 67: 879-888.
13. Ribbe K, Friedrichs H, Begemann M, Grube S, Papiol S, Kastner A et al. The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry 2010; 10: 91.
14. Kastner A, Begemann M, Michel TM, Everts S, Stepniak B, Bach C et al. Autism beyond diagnostic categories: characterization of autistic phenotypes in schizophrenia. BMC Psychiatry 2015; 15: 115.
15. Volzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N et al. Cohort profile: the Study of Health in Pomerania. Int J Epidemiol 2011; 40: 294-307.
16. Stepniak B, Kastner A, Poggi G, Mitjans M, Begemann M, Hartmann A et al. Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes. EMBO Mol Med 2015; 7: 1565-1579.
17. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-276.
18. Franke G. Brief Symptom Inventory (BSI). Beltz: Goettingen, Germany, 2000.
19. Blom G. Statistical Estimates and Transformed Beta-Variables. Wiley: New York, USA, 1958.
20. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
21. Schulz P, Schlotz W, Becker P. Trierer Inventar zur Erfassung von chronischem Streß (TICS): skalenkonstruktion, teststatistische überprüfung und validierung der skala arbeitsüberlastung. Diagnostica 1999; 45: 8-19.
22. Hammer C, Stepniak B, Schneider A, Papiol S, Tantra M, Begemann M et al. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol Psychiatry 2014; 19: 1143-1149.
23. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
24. Fisher RA. The use of multiple measurements in taxonomic problems. Ann Eugenics 1936; 7: 179-188.
25. Breiman L. Random forests. Mach Learn 2001; 45: 5-32.
26. Liaw A, Wiener M. Classification and regression by random Forest. R News 2002; 2/3: 18-22.
27. Bastiaansen JA, Meffert H, Hein S, Huizinga P, Ketelaars C, Pijnenborg M et al. Diagnosing autism spectrum disorders in adults: the use of Autism Diagnostic Observation Schedule (ADOS) module 4. J Autism Dev Disord 2011; 41: 1256-1266.
28. Ehrenreich H, Nave KA. Phenotype-based genetic association studies (PGAS)-towards understanding the contribution of common genetic variants to schizophrenia subphenotypes. Genes 2014; 5: 97-105.
29. Pettersson E, Larsson H, Lichtenstein P. Common psychiatric disorders share the same genetic origin: a multivariate sibling study of the Swedish population. Mol Psychiatry 2015; 21: 717-721.
30. Bush WS, Oetjens MT, Crawford DC. Unravelling the human genome-phenome relationship using phenome-wide association studies. Nat Rev Genet 2016; 17: 129-145.
31. Tost H, Champagne FA, Meyer-Lindenberg A. Environmental influence in the brain, human welfare and mental health. Nat Neurosci 2015; 18: 1421-1431.